Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood cancer journal - 12 May 2023
Sargas Claudia, Ayala Rosa, Larráyoz María J, Chillón María C, Rodriguez-Arboli Eduardo, Bilbao Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Dominguez Juan M, García Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María J, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María J, García-Sanz Ramón, Pérez-Simón José A, Gómez Casares María T, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau
Abstract excerpt
Next-Generation Sequencing is needed for the accurate genetic risk stratification of acute myeloid leukemia according to European LeukemiaNet (ELN) guidelines. We validated and compared the 2022 ELN risk classification in a real-life cohort of 546 intensively and 379 non-intensively treated patients. Among fit patients, those aged ≥65 years old showed worse OS than younger regardless risk classification. Compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.